Cold-Virus Genome Revealed
We may be one step closer to defeating that small but mighty bearer of human misery: the common cold.

Scientists have now sequenced all of the 99 known strains of cold virus. The research, published today in the journal Science, sheds light on the bug’s ubiquity–different viruses can swap DNA sequences, generating new strains that can evade the immune system.
According to a statement from the University of Wisconsin:
The newly sequenced viruses also show … why it is unlikely we will ever have an effective, all-purpose cold vaccine: The existing reservoir of viruses worldwide is huge and, according to the new study, they have a tendency to swap genetic sequences when cells are infected by more than one virus, a phenomenon that can lead to new virus strains and clinical manifestations.
“Having sequenced the complete genomes of these things, we now know you can be infected by more than one virus at a time and that they can recombine (their genes),” [lead author of the new study Ann] Palmenberg [of UW-Madison’s Institute for Molecular Virology] explains. “That’s why we’ll never have a vaccine for the common cold. Nature is very efficient at putting different kinds of paint on the viruses.”
Keep Reading
Most Popular
This new data poisoning tool lets artists fight back against generative AI
The tool, called Nightshade, messes up training data in ways that could cause serious damage to image-generating AI models.
The Biggest Questions: What is death?
New neuroscience is challenging our understanding of the dying process—bringing opportunities for the living.
Rogue superintelligence and merging with machines: Inside the mind of OpenAI’s chief scientist
An exclusive conversation with Ilya Sutskever on his fears for the future of AI and why they’ve made him change the focus of his life’s work.
How to fix the internet
If we want online discourse to improve, we need to move beyond the big platforms.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.